{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:57:25Z","timestamp":1781639845038,"version":"3.54.5"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603440"],"award-info":[{"award-number":["81603440"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fushen Granule (FSG), a Chinese medicine formular, was used clinically to improve the efficiency of dialysis in end-stage renal disease patients receiving peritoneal dialysis treatment. However, the mechanisms of its antifibrotic effect on peritoneal fibrosis (PF) have not yet been studied. In this study, we aimed to identify the potential mechanism of FSG in intervening in PF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Network pharmacology analysis and molecular docking were used to predict the related ingredients and potential targets of FSG in treating PF. TGF-\u03b21 induced MeT5A cells were used for in vitro verification. Label-free proteomics analysis was performed to detect the differentially expressed proteins in TGF-\u03b21 induced MeT5A cells upon treatment with FSG-containing serum. Western blot and immunofluorescence assays were used to evaluate the expression of proteins related to PF and PI3K\/AKT signalling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PPI network analysis showed that TP53, EGFR, HSP90AA1, AKT1, CCND1, MYC, STAT3, SRC and ESR1 constitute the core network. KEGG analysis found that the PI3K\/AKT signalling pathway was significantly enriched. Molecular docking analysis indicated that the main active ingredient from the component\u2013target network can closely integrate with targets in the PI3K\/AKT signalling pathway. Proteomics analysis on TGF-\u03b21-treated MeT5A also indicated that the PI3K\/AKT signalling pathway was closely correlated with the effect of FSG in intervening PF. Further in vitro experimental validation showed that FSG decreased the protein levels of FN, Col \u2160, \u03b1-SMA, ITG\u03b23, PDK1, p-mTOR and p-AKT and reversed the expression of E-cad in TGF-\u03b21-treated MeT5A cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FSG showed therapeutic effects against PF, mainly by inactivating PI3K\/AKT signalling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-026-05333-2","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:02:36Z","timestamp":1773064956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An integrated network pharmacology and proteomics approach reveals the anti-fibrotic effect of Fushen Granule on peritoneal fibrosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Kang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangxing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"issue":"2","key":"5333_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrneph.2016.163","volume":"13","author":"RJ GLASSOCK","year":"2017","unstructured":"Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13(2):104\u201314.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"5333_CR2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.kint.2020.09.003","volume":"98","author":"C Yang","year":"2020","unstructured":"Yang C, Gao B, Zhao X, et al. Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int. 2020;98(6):1419\u201323.","journal-title":"Kidney Int"},{"key":"5333_CR3","doi-asserted-by":"crossref","unstructured":"Zhang L, Zhao MH, Zuol L et al. China Kidney Disease Network (CK-NET) 2015 Annual Data Report. Kidney Int Suppl (2011). 2019;9(1):e1-e81.","DOI":"10.1016\/j.kisu.2018.11.001"},{"issue":"11","key":"5333_CR4","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/ASN.2016010112","volume":"27","author":"R MEHROTRA","year":"2016","unstructured":"Mehrotra R, Devuyst O Daviessj, et al. The Current State of Peritoneal Dialysis. J Am Soc Nephrol. 2016;27(11):3238\u201352.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"5333_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneph.2016.181","volume":"13","author":"PK LI","year":"2017","unstructured":"LI PK, CHOW K M, VAN DE LUIJTGAARDEN M W, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90\u2013103.","journal-title":"Nat Rev Nephrol"},{"key":"5333_CR6","doi-asserted-by":"crossref","unstructured":"DP G, JT C. LC M, High volume peritoneal dialysis vs daily hemodialysis: a randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl. 2008(108):S87\u201393.","DOI":"10.1038\/sj.ki.5002608"},{"issue":"4","key":"5333_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/1744-9987.12660","volume":"22","author":"FF A A-H, I A-R","year":"2018","unstructured":"A A-H, I A-R FF, et al. Acute Kidney Injury in Critically Ill Patients: A Prospective Randomized Study of Tidal Peritoneal Dialysis Versus Continuous Renal Replacement Therapy[J]. Therapeutic apheresis dialysis. 2018;22(4):371\u20139.","journal-title":"Therapeutic apheresis dialysis"},{"key":"5333_CR8","doi-asserted-by":"crossref","unstructured":"HJ, WF, MZ, et al. Urgent-Start Peritoneal Dialysis and Hemodialysis in ESRD Patients: Complications and Outcomes. PLoS ONE. 2016;11(11): e0166181.","DOI":"10.1371\/journal.pone.0166181"},{"issue":"2","key":"5333_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3747\/pdi.2014.00148","volume":"36","author":"A AM","year":"2016","unstructured":"AM A, PG B. Success of Urgent-Start Peritoneal Dialysis in a Large Canadian Renal Program. Perit Dial Int. 2016;36(2):171\u20136.","journal-title":"Perit Dial Int"},{"issue":"3","key":"5333_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","volume":"90","author":"ZHOU","year":"2016","unstructured":"Zhou Q, Bajo MA, Del Peso G, et al. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int. 2016;90(3):515\u201324.","journal-title":"Kidney Int"},{"key":"5333_CR11","doi-asserted-by":"publisher","unstructured":"StrippoliR, Moreno-Vicente R, Battistelli C, et al. Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis. Stem Cells Int. 2016;2016:3543678. https:\/\/doi.org\/10.1155\/2016\/3543678.","DOI":"10.1155\/2016\/3543678"},{"key":"5333_CR12","doi-asserted-by":"publisher","unstructured":"MasolaV, Bonomini M, Borrelli S. Fibrosis of peritoneal membrane as target of new therapies in peritoneal dialysis. Int J Mol Sci. 2022;23(9):4831. https:\/\/doi.org\/10.3390\/ijms23094831.","DOI":"10.3390\/ijms23094831"},{"issue":"9","key":"5333_CR13","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nrneph.2012.144","volume":"8","author":"RV AP","year":"2012","unstructured":"AP RV. Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions. Nat Rev Nephrol. 2012;8(9):542\u201350.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"5333_CR14","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/ASN.2006111292","volume":"18","author":"A LS","year":"2007","unstructured":"LS A, AA, JA S-T, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J Am Soc Nephrol. 2007;18(7):2004\u201313.","journal-title":"J Am Soc Nephrol"},{"key":"5333_CR15","doi-asserted-by":"crossref","unstructured":"JA J-H RSAB et al. Epithelial-to-mesenchymal transition of the mesothelial cell\u2013its role in the response of the peritoneum to dialysis. Nephrology, dialysis, transplantation. 2006;Suppl 2:ii2-7.","DOI":"10.1093\/ndt\/gfl183"},{"issue":"6","key":"5333_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3346\/jkms.2007.22.6.943","volume":"22","author":"L HB","year":"2007","unstructured":"HB L. Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis. J Korean Med Sci. 2007;22(6):943\u20135.","journal-title":"J Korean Med Sci"},{"issue":"9","key":"5333_CR17","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1681\/ASN.2010111197","volume":"22","author":"AA JL","year":"2011","unstructured":"JL AA, RS, et al. Blocking TGF-\u03b21 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol. 2011;22(9):1682\u201395.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"5333_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1681\/ASN.2004060436","volume":"16","author":"M PJ","year":"2005","unstructured":"PJ M. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol. 2005;16(2):425\u201336.","journal-title":"J Am Soc Nephrol"},{"key":"5333_CR19","doi-asserted-by":"crossref","unstructured":"MS, QW, YL, et al Inhibition of hyperglycolysis in mesothelial cells prevents peritoneal fibrosis. Science translational medicine. 2019;11(495):eaav5341.","DOI":"10.1126\/scitranslmed.aav5341"},{"key":"5333_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biopha.2017.01.039","volume":"88","author":"ZDL WJ","year":"2017","unstructured":"WJ ZDL, LY Z. Blocking TGF-\u03b21 by P17 peptides attenuates gastric cancer cell induced peritoneal fibrosis and prevents peritoneal dissemination in vitro and in vivo[J]. Biomed pharmacotherapy. 2017;88:27\u201333.","journal-title":"Biomed pharmacotherapy"},{"issue":"2","key":"5333_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ki.2013.81","volume":"84","author":"AN TU","year":"2013","unstructured":"TU AN. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-\u03b21 signaling. Kidney Int. 2013;84(2):297\u2013307.","journal-title":"Kidney Int"},{"issue":"3","key":"5333_CR22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajpath.2013.05.019","volume":"183","author":"Y Q Z, M","year":"2013","unstructured":"QZ, MY. miR-30a negatively regulates TGF-\u03b21-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1. Am J Pathol. 2013;183(3):808\u201319.","journal-title":"Am J Pathol"},{"issue":"3","key":"5333_CR23","doi-asserted-by":"publisher","first-page":"e5879","DOI":"10.1097\/MD.0000000000005879","volume":"96","author":"X ZJ","year":"2017","unstructured":"ZJ X. Liuwei Dihuang pill treats diabetic nephropathy in rats by inhibiting of TGF-\u03b2\/SMADS, MAPK, and NF-kB and upregulating expression of cytoglobin in renal tissues. Medicine. 2017;96(3):e5879.","journal-title":"Medicine"},{"key":"5333_CR24","doi-asserted-by":"publisher","unstructured":"XW,XL, LN W, et al. Buyang Huanwu Decoction Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats via Downregulation of Related Protein and Gene Expression. Evidence-based complementary alternative medicine.2018;2018:9185485. https:\/\/doi.org\/10.1155\/2018\/9185485.","DOI":"10.1155\/2018\/9185485"},{"key":"5333_CR25","doi-asserted-by":"publisher","first-page":"108863","DOI":"10.1016\/j.biopha.2019.108863","volume":"114","author":"C FF","year":"2019","unstructured":"FF C, YQ B. Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis. Biomed pharmacotherapy. 2019;114:108863.","journal-title":"Biomed pharmacotherapy"},{"key":"5333_CR26","doi-asserted-by":"publisher","first-page":"112501","DOI":"10.1016\/j.jep.2019.112501","volume":"251","author":"C JIANG","year":"2020","unstructured":"Jiang C, Lin W, Wang L, et al. Fushen Granule, A Traditional Chinese Medicine, ameliorates intestinal mucosal dysfunction in peritoneal dialysis rat model by regulating p38MAPK signaling pathway. J Ethnopharmacol. 2020;251:112501.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"5333_CR27","first-page":"699","volume":"49","author":"B YANG","year":"2021","unstructured":"Yang B, Wang M. The effect of Fushen recipe on peritoneal ultrafiltration function and VEGF-Notch signal pathway in uremic peritoneal dialysis rats. Tianjin Med J. 2021;49(7):699\u2013705.","journal-title":"Tianjin Med J"},{"issue":"7","key":"5333_CR28","first-page":"1500","volume":"45","author":"Y LEI","year":"2018","unstructured":"Lei Y, Yang B, Wang M, et al. Effect of Fushen Decoction on Transdifferentiation of Rat Peritoneal Mesothelial Cells and Its Mechanism. Liaoning J Traditional Chin Med. 2018;45(7):1500\u20133.","journal-title":"Liaoning J Traditional Chin Med"},{"issue":"7","key":"5333_CR29","first-page":"521","volume":"35","author":"Y LEI","year":"2018","unstructured":"Lei Y, Yang B, Pei M, et al. Effects of Fushen recipe on expression of TGF-\u03b21, E-cadherin and \u03b1-SMA in peritoneal mesenchymal membranes of uremia rats. Tianjin J Traditional Chin Med. 2018;35(7):521\u20135.","journal-title":"Tianjin J Traditional Chin Med"},{"key":"5333_CR30","doi-asserted-by":"publisher","first-page":"153561","DOI":"10.1016\/j.phymed.2021.153561","volume":"86","author":"W LIN","year":"2021","unstructured":"Lin W, Jiang C, YU H, et al. The effects of Fushen Granule on the composition and function of the gut microbiota during Peritoneal Dialysis-Related Peritonitis. Phytomedicine. 2021;86:153561.","journal-title":"Phytomedicine"},{"key":"5333_CR31","doi-asserted-by":"crossref","unstructured":"LiuH, Zeng L, Yang K et al. A Network Pharmacology Approach to Explore the Pharmacological Mechanism of Xiaoyao Powder on Anovulatory Infertility. Evidence-based complementary alternative medicine. 2016;2016:2960372. http:\/\/dx.doi.org\/10.1155\/2016\/2960372.","DOI":"10.1155\/2016\/2960372"},{"key":"5333_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpba.2017.04.012","volume":"141","author":"T XU","year":"2017","unstructured":"Xu T, Li S, Sun Y, et al. Systematically characterize the absorbed effective substances of Wutou Decoction and their metabolic pathways in rat plasma using UHPLC-Q-TOF-MS combined with a target network pharmacological analysis. J Pharm biomedical Anal. 2017;141:95\u2013107.","journal-title":"J Pharm biomedical Anal"},{"key":"5333_CR33","first-page":"112501","volume":"251","author":"J C","year":"2019","unstructured":"CJ. Fushen Granule, A Traditional Chinese Medicine, ameliorates intestinal mucosal dysfunction in peritoneal dialysis rat model by regulating p38MAPK signaling pathway. J Ethnopharmacol. 2019;251:112501.","journal-title":"J Ethnopharmacol"},{"issue":"47","key":"5333_CR34","first-page":"124","volume":"01","author":"J LI","year":"2020","unstructured":"Li J, Yang B. Evidence of Network Pharmacology of Fushen Granule Preventing Peritoneal Fibrosis Based on Harmonizing Method. Liaoning J Trad Chin Med. 2020;01(47):124\u20137.","journal-title":"Liaoning J Trad Chin Med"},{"issue":"2","key":"5333_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10565-018-9438-9","volume":"35","author":"S LUPINACCI","year":"2019","unstructured":"Lupinacci S, Perri A, Toteda G, et al. Olive leaf extract counteracts epithelial to mesenchymal transition process induced by peritoneal dialysis, through the inhibition of TGF-\u03b21 signaling. Cell Biol Toxicol. 2019;35(2):95\u2013109.","journal-title":"Cell Biol Toxicol"},{"key":"5333_CR36","doi-asserted-by":"crossref","unstructured":"Kim K, Sheppard D. Chapman H. TGF-\u03b21 Signaling and Tissue Fibrosis. Cold Spring Harbor perspectives in biology. 2018;10(4):a022293.","DOI":"10.1101\/cshperspect.a022293"},{"issue":"6","key":"5333_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"H MENG X, NIKOLIC-PATERSON D, LAN","year":"2016","unstructured":"Meng X, Nikolic-Paterson D, Lan H. TGF-\u03b2: the master regulator of fibrosis. J Nat reviews Nephrol. 2016;12(6):325\u201338.","journal-title":"J Nat reviews Nephrol"},{"issue":"9","key":"5333_CR38","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1111\/jcmm.13725","volume":"22","author":"W QIAN","year":"2018","unstructured":"Qian W, Cai X. Astragaloside IV modulates TGF-\u03b21-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. J Cell Mol Med. 2018;22(9):4354\u201365.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"5333_CR39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00441-016-2464-0","volume":"365","author":"R STONE","year":"2016","unstructured":"Stone R, Pastar I, Ojeh N, et al. Epithelial-mesenchymal transition in tissue repair and fibrosis. Cell tissue Res. 2016;365(3):495\u2013506.","journal-title":"Cell tissue Res"},{"issue":"6","key":"5333_CR40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/jb\/mvq043","volume":"147","author":"A YOSHIMURA","year":"2010","unstructured":"Yoshimura A, Wakabayashi Y. Cellular and molecular basis for the regulation of inflammation by TGF-\u03b2. J Biochem. 2010;147(6):781\u201392.","journal-title":"J Biochem"},{"issue":"3","key":"5333_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1681\/ASN.2008040424","volume":"20","author":"M YU","year":"2009","unstructured":"Yu M, Shin K, Kim J, et al. HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium. J Am Soc Nephrol. 2009;20(3):567\u201381.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"5333_CR42","doi-asserted-by":"publisher","first-page":"e61165","DOI":"10.1371\/journal.pone.0061165","volume":"8","author":"L JES\u00faS","year":"2013","unstructured":"Jes\u00fas L, Pilar S, Gloria DP, et al. Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis. PLoS ONE. 2013;8(4):e61165.","journal-title":"PLoS ONE"},{"issue":"10","key":"5333_CR43","doi-asserted-by":"publisher","first-page":"e109628","DOI":"10.1371\/journal.pone.0109628","volume":"9","author":"IK C T","year":"2014","unstructured":"IK CT, Hye-Young K, Sik KK, et al. The Effect of Statin on Epithelial-Mesenchymal Transition in Peritoneal Mesothelial Cells. PLoS ONE. 2014;9(10):e109628.","journal-title":"PLoS ONE"},{"issue":"5","key":"5333_CR44","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jcpt.12318","volume":"40","author":"P DITSAWANON","year":"2015","unstructured":"Ditsawanon P. Preserving the peritoneal membrane in long-term peritoneal dialysis patients. J Clin Pharm Ther. 2015;40(5):508\u201316.","journal-title":"J Clin Pharm Ther"},{"key":"5333_CR45","doi-asserted-by":"publisher","first-page":"628671","DOI":"10.3389\/fphar.2021.628671","volume":"12","author":"L RUIQI","year":"2021","unstructured":"Ruiqi L, Ming P, Qihang S, et al. Saikosaponin D Inhibits Peritoneal Fibrosis in Rats With Renal Failure by Regulation of TGF\u03b21\/ BMP7 \/ Gremlin1\/ Smad Pathway. Front Pharmacol. 2021;12:628671.","journal-title":"Front Pharmacol"},{"issue":"Pt A","key":"5333_CR46","first-page":"116874","volume":"318","author":"H DAI","year":"2023","unstructured":"Dai H, Shan Y, Yu M, et al. Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis. J Ethnopharmacol. 2023;318(Pt A):116874.","journal-title":"J Ethnopharmacol"},{"key":"5333_CR47","doi-asserted-by":"publisher","unstructured":"HuangL, Wang Z, Li Y. Intervention Mechanism of Niao Du Kang Mixture on the EMT Process of Peritoneal Fibrosis Based on the Wnt\/\u03b2-Catenin Signaling Pathway. Evid Based Complement Alternat Med, 2022;2022:2089483. https:\/\/doi.org\/10.1155\/2022\/2089483.","DOI":"10.1155\/2022\/2089483"},{"key":"5333_CR48","doi-asserted-by":"publisher","first-page":"116306","DOI":"10.1016\/j.jep.2023.116306","volume":"309","author":"L ZHAO","year":"2023","unstructured":"Zhao L, Zhang H, Li N, et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol. 2023;309:116306.","journal-title":"J Ethnopharmacol"},{"key":"5333_CR49","doi-asserted-by":"publisher","first-page":"1158633","DOI":"10.3389\/fnut.2023.1158633","volume":"10","author":"SANNAPPA GOWDA N G","year":"2023","unstructured":"Sannappa Gowda NG, Shiragannavar VD, Puttahanumantharayappa LD, et al. Quercetin activates vitamin D receptor and ameliorates breast cancer induced hepatic inflammation and fibrosis[J]. Front Nutr. 2023;10:1158633.","journal-title":"Front Nutr"},{"issue":"Pt A","key":"5333_CR50","doi-asserted-by":"publisher","first-page":"116874","DOI":"10.1016\/j.jep.2023.116874","volume":"318","author":"H DAI","year":"2024","unstructured":"Dai H, Shan Y, Yu M, et al. Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis. J Ethnopharmacol. 2024;318(Pt A):116874.","journal-title":"J Ethnopharmacol"},{"key":"5333_CR51","doi-asserted-by":"publisher","first-page":"984611","DOI":"10.3389\/fphar.2022.984611","volume":"13","author":"JB ZHANG","year":"2022","unstructured":"Zhang JB, Jin HL, Feng XY, et al. The combination of Lonicerae Japonicae Flos and Forsythiae Fructus herb-pair alleviated inflammation in liver fibrosis. Front Pharmacol. 2022;13:984611.","journal-title":"Front Pharmacol"},{"key":"5333_CR52","doi-asserted-by":"publisher","first-page":"1153503","DOI":"10.3389\/fphar.2023.1153503","volume":"14","author":"X LU","year":"2023","unstructured":"Lu X, Wu K, Jiang S, et al. Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation. Front Pharmacol. 2023;14:1153503.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5333_CR53","first-page":"106","volume":"11","author":"X WAN","year":"2019","unstructured":"Wan X, Huang H, Wang X, et al. Euonymus alatus and its monomers alleviate liver fibrosis both in mice and LX2 cells by blocking T\u03b2R1-Smad2\/3 and TNF-\u03b1-NF-\u03baB pathways. Am J translational Res. 2019;11(1):106\u201319.","journal-title":"Am J translational Res"},{"issue":"3","key":"5333_CR54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/0886022X.2011.559681","volume":"33","author":"J CHUNMING","year":"2011","unstructured":"Chunming J, Miao Z. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model. Ren Fail. 2011;33(3):355\u201362.","journal-title":"Ren Fail"},{"key":"5333_CR55","doi-asserted-by":"publisher","first-page":"778479","DOI":"10.3389\/fphys.2022.778479","volume":"13","author":"M JIA","year":"2022","unstructured":"Jia M, Qiu H, Lin L, et al. Inhibition of PI3K\/AKT\/mTOR Signalling Pathway Activates Autophagy and Suppresses Peritoneal Fibrosis in the Process of Peritoneal Dialysis. Front Physiol. 2022;13:778479.","journal-title":"Front Physiol"},{"key":"5333_CR56","doi-asserted-by":"publisher","first-page":"116343","DOI":"10.1016\/j.jep.2023.116343","volume":"309","author":"J SUN","year":"2023","unstructured":"Sun J, Tang L, Shan Y, et al. TMT quantitative proteomics and network pharmacology reveal the mechanism by which asiaticoside regulates the JAK2\/STAT3 signaling pathway to inhibit peritoneal fibrosis. J Ethnopharmacol. 2023;309:116343.","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"5333_CR57","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1681\/ASN.2015030299","volume":"27","author":"L WANG","year":"2016","unstructured":"Wang L, Liu N, Xiong C, et al. Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis. J Am Soc Nephrol. 2016;27(9):2631\u201344.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"5333_CR58","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s13577-023-00859-w","volume":"36","author":"N LIU","year":"2023","unstructured":"Liu N, Liu D, Cao S, et al. Silencing of adipocyte enhancer-binding protein 1 (AEBP1) alleviates renal fibrosis in vivo and in vitro via inhibition of the \u03b2-catenin signaling pathway. Hum Cell. 2023;36(3):972\u201386.","journal-title":"Hum Cell"},{"key":"5333_CR59","doi-asserted-by":"publisher","first-page":"116946","DOI":"10.1016\/j.jep.2023.116946","volume":"318","author":"X SUN","year":"2023","unstructured":"Sun X, Liu Xiangh. Jingfang Granules alleviates bleomycin-induced acute lung injury through regulating PI3K\/Akt\/mTOR signaling pathway. J Ethnopharmacol. 2023;318:116946.","journal-title":"J Ethnopharmacol"},{"key":"5333_CR60","doi-asserted-by":"crossref","unstructured":"Gu H, Li J, Ni Y. Sinomenine improves renal fibrosis by regulating mesenchymal stem cell-derived exosomes and affecting autophagy levels. J Environmental toxicology. 2023;38(10):2524\u20132537.","DOI":"10.1002\/tox.23890"},{"key":"5333_CR61","doi-asserted-by":"crossref","unstructured":"Yan L, Hou C, Liu J, et al. Local administration of liposomal-based Plekhf1 gene therapy attenuates pulmonary fibrosis by modulating macrophage polarization. Science China-Life sciences. 2023;66(11):2571\u20132586.","DOI":"10.1007\/s11427-022-2314-8"},{"key":"5333_CR62","doi-asserted-by":"publisher","first-page":"1137332","DOI":"10.3389\/fimmu.2023.1137332","volume":"14","author":"X ZHOU","year":"2023","unstructured":"Zhou X, Chen H, Shi Y, et al. Histone deacetylase 8 inhibition prevents the progression of peritoneal fibrosis by counteracting the epithelial-mesenchymal transition and blockade of M2 macrophage polarization. Front Immunol. 2023;14:1137332.","journal-title":"Front Immunol"},{"issue":"2","key":"5333_CR63","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s12011-014-0091-8","volume":"161","author":"J LIU","year":"2014","unstructured":"Liu J, Zeng L, Zhao Y, et al. Selenium suppresses lipopolysaccharide-induced fibrosis in peritoneal mesothelial cells through inhibition of epithelial-to-mesenchymal transition. Biol Trace Elem Res. 2014;161(2):202\u20139.","journal-title":"Biol Trace Elem Res"},{"key":"5333_CR64","doi-asserted-by":"publisher","unstructured":"UddinN, Ali N, Uddin Z et al. Evaluation of Cholinesterase Inhibitory Potential of Different Genotypes of Ziziphus nummularia, Their HPLC-UV, and Molecular Docking Analysis. Molecules. 2020;25(21):5011. https:\/\/doi.org\/10.3390\/molecules25215011.","DOI":"10.3390\/molecules25215011"},{"issue":"5","key":"5333_CR65","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.tjog.2018.08.020","volume":"57","author":"MW WEN Y C, DU M K, LI","year":"2018","unstructured":"Wen YC, Du MK, Li MW, et al. EphA2-positive human umbilical cord-derived mesenchymal stem cells exert anti-fibrosis and immunomodulatory activities via secretion of prostaglandin E2. Taiwan J Obstet Gynecol. 2018;57(5):722\u20135.","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"6","key":"5333_CR66","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/cvr\/cvad029","volume":"119","author":"Y LU","year":"2023","unstructured":"Lu Y, Zhao N, Wu Y, et al. Inhibition of phosphoglycerate kinase 1 attenuates autoimmune myocarditis by reprogramming CD4\u2009+\u2009T cell metabolism. Cardiovasc Res. 2023;119(6):1377\u201389.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"5333_CR67","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jhep.2012.11.011","volume":"58","author":"J LI","year":"2013","unstructured":"Li J, Ghazwani M, Zhang Y, et al. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. J Hepatol. 2013;58(3):522\u20138.","journal-title":"J Hepatol"},{"issue":"3","key":"5333_CR68","first-page":"279","volume":"39","author":"H ZHAO","year":"2019","unstructured":"Zhao H, Yang K, Liu Q, et al. [Expression of calponin-1 and its pathogenic role in systemic sclerosis]. Nan Fang Yi Ke Da Xue Xue Bao. 2019;39(3):279\u201385.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"9","key":"5333_CR69","doi-asserted-by":"publisher","first-page":"e45076","DOI":"10.1371\/journal.pone.0045076","volume":"7","author":"S BALASUBRAMANIAN","year":"2012","unstructured":"Balasubramanian S, Quinones L, Kasiganesan H, et al. \u03b23 integrin in cardiac fibroblast is critical for extracellular matrix accumulation during pressure overload hypertrophy in mouse. PLoS ONE. 2012;7(9):e45076.","journal-title":"PLoS ONE"},{"issue":"2","key":"5333_CR70","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.stem.2021.10.009","volume":"29","author":"V JANBANDHU","year":"2022","unstructured":"Janbandhu V, Tallapragada V, Patrick R, et al. Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction. Cell Stem Cell. 2022;29(2):281\u2013e297212.","journal-title":"Cell Stem Cell"},{"issue":"9","key":"5333_CR71","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/aps.2017.202","volume":"39","author":"CHENGS LV X M, LI M D","year":"2018","unstructured":"LV XM, LI MD Chengs, et al. Neotuberostemonine inhibits the differentiation of lung fibroblasts into myofibroblasts in mice by regulating HIF-1\u03b1 signaling. Acta Pharmacol Sin. 2018;39(9):1501\u201312.","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"5333_CR72","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/abbs\/gmy056","volume":"50","author":"Y SU","year":"2018","unstructured":"Su Y, Tian H. Integrin \u03b23 inhibits hypoxia-induced apoptosis in cardiomyocytes. Acta Biochim Biophys Sin (Shanghai). 2018;50(7):658\u201365.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"5333_CR73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13578-020-00416-0","volume":"10","author":"F XU","year":"2020","unstructured":"Xu F, Na L, Li Y, et al. Roles of the PI3K\/AKT\/mTOR signalling pathways in neurodegenerative diseases and tumours. J Cell bioscience. 2020;10:54.","journal-title":"J Cell bioscience"},{"issue":"11","key":"5333_CR74","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X HUANG","year":"2018","unstructured":"Huang X, Liu G, Guo J, et al. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483\u201396.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"5333_CR75","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/jcb.25950","volume":"119","author":"A BAHRAMI","year":"2018","unstructured":"Bahrami A, Khazaei M, Hasanzadeh M, et al. Therapeutic Potential of Targeting PI3K\/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress. J Cell Biochem. 2018;119(3):2460\u20139.","journal-title":"J Cell Biochem"},{"key":"5333_CR76","doi-asserted-by":"publisher","first-page":"117470","DOI":"10.1016\/j.lfs.2020.117470","volume":"249","author":"F RAHMANI","year":"2020","unstructured":"Rahmani F, Asgharzadeh F, Avan A, et al. Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K\/AKT and NF-\u03baB signaling pathways. Life Sci. 2020;249:117470.","journal-title":"Life Sci"},{"issue":"11","key":"5333_CR77","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41374-019-0281-2","volume":"99","author":"H WAN","year":"2019","unstructured":"Wan H, Xie T, Xu Q, et al. Thy-1 depletion and integrin \u03b23 upregulation-mediated PI3K-Akt-mTOR pathway activation inhibits lung fibroblast autophagy in lipopolysaccharide-induced pulmonary fibrosis. Lab Invest. 2019;99(11):1636\u201349.","journal-title":"Lab Invest"},{"issue":"22","key":"5333_CR78","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.21037\/atm-21-5476","volume":"9","author":"BL KY","year":"2021","unstructured":"KY BL. Knockdown of phosphoinositide-dependent kinase 1 (PDK1) inhibits fibrosis and inflammation in lipopolysaccharide-induced acute lung injury rat model by attenuating NF-\u03baB\/p65 pathway activation. Annals translational Med. 2021;9(22):1671.","journal-title":"Annals translational Med"},{"issue":"3","key":"5333_CR79","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1096\/fj.201901981R","volume":"34","author":"H LU","year":"2020","unstructured":"Lu H, Chen W, Liu W, et al. Molecular hydrogen regulates PTEN-AKT-mTOR signaling via ROS to alleviate peritoneal dialysis-related peritoneal fibrosis. FASEB J. 2020;34(3):4134\u201346.","journal-title":"FASEB J"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05333-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:39:25Z","timestamp":1781638765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-026-05333-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5333"],"URL":"https:\/\/doi.org\/10.1186\/s12906-026-05333-2","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"24 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Animal Research Committee at Tianjin University of Traditional Chinese Medicine (approval no. TCM-LAEC2019097) and in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health, 8th edition, 2011). Furthermore, the study was carried out under the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"143"}}